New Plain Language Labeling Rules Come Into Play For Non-Rx Drugs In Canada
Executive Summary
Sponsors of non-prescription drugs in Canada have until June 2021 to comply with new labeling obligations aimed at making it easier for patients and healthcare professionals to understand important information about the safe use of medicines.
You may also be interested in...
Canada Tilts At Unneeded Fixes In Self-Care Product Regulation Overhaul – Industry
Health Canada says its planned overhaul will not scrap the current natural health product framework, but industry is skeptical. In a Council for Responsible Nutrition webinar, an industry consultant says marketers of OTC drugs, supplements and cosmetics are discussing the proposal's negative implications with the agency.
'Plain language review' in store for all drug labels in Canada under new regs
Health Canada is seeking comments on its plans to implement new plain language labeling regulations for prescription drugs1.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.